Skip to content
ALS News Today logo Newsletter
Newsletter
  • About ALS
    What is ALS?
    Causes and risk factors
    Diagnosis
    Symptoms
    • Speech problems
    • Breathing and swallowing
    • Pseudobulbar affect
    Types of ALS
    • Familial ALS
    • Sporadic ALS
    Living with ALS
    • Mental health
    • Diet
    • Exercise
    • Aids and adaptations
  • Treatments
    Approved treatments
    Experimental treatments
    Non-drug treatments
  • News
  • Columns
    Joyful Sorrow — Kristin Neva
    Living Well With ALS — Dagmar Munn
    Thunder Road — Juliet Taylor
    Archived columns
    • OutSpoken — James Clingman
    • The Mighty Mind — Rachel Doboga
    In memoriam
    • Notes From the ALS Front — Rick Jobus
  • Forums
  • Advocacy partners
  • What can we help you find today?

  • Social Clips
  • Last Week’s Top-3 Most Read Posts On ALS

Last Week’s Top-3 Most Read Posts On ALS

admin avatar

by admin | January 11, 2016

Share this article:

Share article via email
  • Share on Facebook
  • Share on Twitter
  • Share on Reddit
  • Share via Email

news_8-22

Read the Articles Here:

Dysfunctional ALS Patient Skin-Derived Muscle Neurons Rescued by Kenpaullone

ALS and Other Neurological Disorders May Benefit from Prions Created in Lab

Genervon’s GM604 May Slow Disease Progression in ALS Patients

Print This Page

Tags

Genervon, Genervon Biopharmaceuticals, gm604, most read

Recent Posts

  • Canadian ALS advocates lobby for research investment
  • Is ALS an autoimmune disease? New evidence says maybe yes.
  • Northwestern researcher is hoping to change how ALS is treated
  • Targeting FGF21 hormone may slow ALS disease progression
  • Model identifies ALS subtypes to help design targeted treatment


Recommended reading

An illustration shows a microscopic view of red and white blood cells.
October 7, 2025 News by Marisa Wexler, MS

Is ALS an autoimmune disease? New evidence says maybe yes.

Northwestern University professor Hande Ozdinler is pictured in a headshot photo.
October 6, 2025 News by Agata Boxe

Northwestern researcher is hoping to change how ALS is treated

A researcher prepares a petri dish in a lab.
October 3, 2025 News by Lila Levinson, PhD

Targeting FGF21 hormone may slow ALS disease progression

Bionews, Inc.

3 W Garden St
Suite 700
Pensacola, FL 32502
Website: bionews.com
Email: [email protected]
Phone: 1-800-936-1363

  • About Us
  • Leadership
  • Our Culture
  • Editorial Policy
  • Advertising Policy
  • Corrections Policy
  • Terms of Service
  • Privacy Policy
  • Careers
  • Contact Us
Disclaimer

This site is strictly a news and information website about the disease. It does not provide medical advice, diagnosis or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.

Copyright © 2013-2025 All rights reserved.